1.Special issue on neurodegenerative diseases and their therapeutic approaches.
Experimental & Molecular Medicine 2015;47(3):e146-
No abstract available.
Humans
;
Neurodegenerative Diseases/*drug therapy/*etiology
2.Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go.
Song LI ; Congcong JIA ; Tianbai LI ; Weidong LE
Neuroscience Bulletin 2021;37(12):1735-1744
Parkinson's disease (PD), the second most common neurodegenerative disease, is clinically characterized by both motor and non-motor symptoms. Although overall great achievements have been made in elucidating the etiology and pathogenesis of PD, the exact mechanisms of this complicated systemic disease are still far from being clearly understood. Consequently, most of the currently-used diagnostic tools and therapeutic options for PD are symptomatic. In this perspective review, we highlight the hot topics in recent PD research for both clinicians and researchers. Some of these hot topics, such as sleep disorders and gut symptoms, have been neglected but are currently emphasized due to their close association with PD. Following these research directions in future PD research may help understand the nature of the disease and facilitate the discovery of new strategies for the diagnosis and therapy of PD.
Humans
;
Neurodegenerative Diseases
;
Parkinson Disease/therapy*
;
Sleep Wake Disorders/therapy*
3.Light therapy: a new option for neurodegenerative diseases.
Yu-Lu LIU ; Si-Yi GONG ; Shu-Ting XIA ; Ya-Li WANG ; Hao PENG ; Yun SHEN ; Chun-Feng LIU
Chinese Medical Journal 2020;134(6):634-645
Given the increasing incidence of neurodegenerative disease (ND), recent research efforts have intensified the search for curative treatments. Despite significant research, however, existing therapeutic options for ND can only slow down the progression of the disease, but not provide a cure. Light therapy (LT) has been used to treat some mental and sleep disorders. This review illustrates recent studies of the use of LT in patients with ND and highlights its potential for clinical applications. The literature was collected from PubMed through June 2020. Selected studies were primarily English articles or articles that could be obtained with English abstracts and Chinese main text. Articles were not limited by type. Additional potential publications were also identified from the bibliographies of identified articles and the authors' reference libraries. The identified literature suggests that LT is a safe and convenient physical method of treatment. It may alleviate sleep disorders, depression, cognitive function, and other clinical symptoms. However, some studies have reported limited or no effects. Therefore, LT represents an attractive therapeutic approach for further investigation in ND. LT is an effective physical form of therapy and a new direction for research into treatments for ND. However, it requires further animal experiments to elucidate mechanisms of action and large, double-blind, randomized, and controlled trials to explore true efficacy in patients with ND.
Animals
;
Humans
;
Neurodegenerative Diseases/therapy*
;
Phototherapy
;
Randomized Controlled Trials as Topic
4.The Relationship Between the Gut Microbiome and Neurodegenerative Diseases.
Xueling ZHU ; Bo LI ; Pengcheng LOU ; Tingting DAI ; Yang CHEN ; Aoxiang ZHUGE ; Yin YUAN ; Lanjuan LI
Neuroscience Bulletin 2021;37(10):1510-1522
Many recent studies have shown that the gut microbiome plays important roles in human physiology and pathology. Also, microbiome-based therapies have been used to improve health status and treat diseases. In addition, aging and neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, have become topics of intense interest in biomedical research. Several researchers have explored the links between these topics to study the potential pathogenic or therapeutic effects of intestinal microbiota in disease. But the exact relationship between neurodegenerative diseases and gut microbiota remains unclear. As technology advances, new techniques for studying the microbiome will be developed and refined, and the relationship between diseases and gut microbiota will be revealed. This article summarizes the known interactions between the gut microbiome and neurodegenerative diseases, highlighting assay techniques for the gut microbiome, and we also discuss the potential therapeutic role of microbiome-based therapies in diseases.
Alzheimer Disease/therapy*
;
Gastrointestinal Microbiome
;
Humans
;
Microbiota
;
Neurodegenerative Diseases/therapy*
;
Parkinson Disease/therapy*
5.Progress on the mechanism and treatment of Parkinson's disease-related pathological pain.
Lin-Lin TANG ; Hao-Jun YOU ; Jing LEI
Acta Physiologica Sinica 2023;75(4):595-603
Parkinson's disease (PD) is a common neurodegenerative disease characterized by motor symptoms, including bradykinesia, resting tremor, and progressive rigidity. More recently, non-motor symptoms of PD, such as pain, depression and anxiety, and autonomic dysfunction, have attracted increasing attention from scientists and clinicians. As one of non-motor symptoms, pain has high prevalence and early onset feature. Because the mechanism of PD-related pathological pain is unclear, the clinical therapy for treating PD-related pathological pain is very limited, with a focus on relieving the symptoms. This paper reviewed the clinical features, pathogenesis, and therapeutic strategies of PD-related pathological pain and discussed the mechanism of the chronicity of PD-related pathological pain, hoping to provide useful data for the study of drugs and clinical intervention for PD-related pathological pain.
Humans
;
Parkinson Disease/therapy*
;
Neurodegenerative Diseases
;
Autonomic Nervous System Diseases/complications*
;
Anxiety
;
Pain/etiology*
6.Progress on the role of Kalirin-7 in exercise intervention-mediated improvement of neurodegenerative diseases.
Acta Physiologica Sinica 2023;75(5):659-670
Guanine nucleotide exchange factor Kalirin-7 (Kal-7) is a key factor in synaptic plasticity and plays an important regulatory role in the brain. Abnormal synaptic function leads to the weakening of cognitive functions such as learning and memory, accompanied by abnormal expression of Kal-7, which in turn induces a variety of neurodegenerative diseases. Exercise can upregulate the expression of Kal-7 in related brain regions to alleviate neurodegenerative diseases. By reviewing the literature on Kal-7 and neurodegenerative diseases, as well as the research progress of exercise intervention, this paper summarizes the role and possible mechanism of Kal-7 in the improvement of neurodegenerative diseases by exercise and provides a new rationale for the basic and clinical research on the prevention and treatment of neurodegenerative diseases by exercise.
Humans
;
Neurodegenerative Diseases/therapy*
;
Guanine Nucleotide Exchange Factors/metabolism*
;
Exercise Therapy
7.Effects of resveratrol-induced cellular autophagy in control of neurodegenerative diseases.
Acta Pharmaceutica Sinica 2016;51(1):18-22
Cellular autophagy is a major degradative pathway for clearance of aggregate-prone proteins and damaged organelles. It plays an important role in regulating cellular homeostasis, cell growth and development, and disease development. Dysfunctional autophagy contributes to the pathology of various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease, in which specific pathological protein accumulation occurs. A growing body of evidence suggests that resveratrol plays a significantly role in the regulation of autophagy and clearance of pathological proteins. Resveratrol is a potential drug for neurodegenerative diseases therapy. This review focuses on the effects of resveratrol on cellular autophagy and clinical application in the control of neurodegenerative diseases.
Alzheimer Disease
;
Autophagy
;
Humans
;
Huntington Disease
;
Neurodegenerative Diseases
;
drug therapy
;
Parkinson Disease
;
Stilbenes
;
pharmacology
8.Cellular models for disease exploring and drug screening.
Protein & Cell 2010;1(4):355-362
The biopharmaceutical industry has been greatly promoted by the application of drug and disease models, including both animal and cellular models. In particular, the emergence of induced pluripotent stem cells (iPSC) makes it possible to create a large number of disease-specific cells in vitro. This review introduces the most widely applied models and their specialties.
Animals
;
Drug Evaluation, Preclinical
;
methods
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
Models, Biological
;
Neurodegenerative Diseases
;
therapy
9.CRISPR-Based Genome-Editing Tools for Huntington's Disease Research and Therapy.
Yiyang QIN ; Shihua LI ; Xiao-Jiang LI ; Su YANG
Neuroscience Bulletin 2022;38(11):1397-1408
Huntington's disease (HD) is an autosomal dominantly-inherited neurodegenerative disease, which is caused by CAG trinucleotide expansion in exon 1 of the Huntingtin (HTT) gene. Although HD is a rare disease, its monogenic nature makes it an ideal model in which to understand pathogenic mechanisms and to develop therapeutic strategies for neurodegenerative diseases. Clustered regularly-interspaced short palindromic repeats (CRISPR) is the latest technology for genome editing. Being simple to use and highly efficient, CRISPR-based genome-editing tools are rapidly gaining popularity in biomedical research and opening up new avenues for disease treatment. Here, we review the development of CRISPR-based genome-editing tools and their applications in HD research to offer a translational perspective on advancing the genome-editing technology to HD treatment.
Humans
;
Gene Editing
;
Huntington Disease/therapy*
;
CRISPR-Cas Systems/genetics*
;
Neurodegenerative Diseases
10.Advances in fecal microbiota transplantation for treatment of Parkinson's disease.
Minna ZHANG ; Honggang WANG ; Liujun XUE ; Xiaozhong YANG
Chinese Journal of Biotechnology 2021;37(11):3812-3819
Parkinson's disease (PD) is a common neurodegenerative disease in middle-aged and elderly people. Patients with PD often suffer from gastrointestinal symptoms in the early stage of the disease. Several studies have confirmed that gut microbiota is involved in the progress of PD. As one of the most effective ways to reconstruct the gut microbiota, fecal microbiota transplantation (FMT) has shown potential therapeutic effects on PD. This review summarizes the basic and clinical studies of FMT in the treatment of PD.
Aged
;
Fecal Microbiota Transplantation
;
Gastrointestinal Microbiome
;
Humans
;
Middle Aged
;
Neurodegenerative Diseases
;
Parkinson Disease/therapy*